Clover Health Investments, Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Clover Health Investments, Corp. generated cash of -$115,871,000, which is more than the previous year. Cash used in financing activities reached the amount of -$33,861,000 last year. Net change in cash is therefore -$9,719,000.
Cash Flow
| 2019 | -159.87M | -181.90M | 333.97M |
|---|---|---|---|
| 2020 | -2.22M | -828M | 858.23M |
| 2021 | -282.32M | -435.44M | 925.39M |
| 2022 | -203.92M | 95.13M | -4.96M |
| 2023 | -115.87M | 140.01M | -33.86M |
CLOV Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 186.21M | 299.96M | 92.34M | 67.59M | 75.40M |
Operating activities | |||||
Net income | -213.36M | -338.84M | -587.75M | -6.74M | -363.73M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 2.50M | 1.18M | 1.24M | 555K | 551K |
Stock-based compensation expense | 140.93M | 164.30M | 163.72M | 7.07M | 3.30M |
| Deferred income tax benefit | 140.93M | 164.30M | 163.72M | 7.07M | 3.30M |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | -8.02M | -9.39M | -34.53M | -6.96M |
Inventories | 0 | 8.02M | 9.39M | 2.22M | 6.96M |
Accounts payable | 4.73M | 7.63M | 5.30M | 10.84M | 6.29M |
Cash generated by operating activities | -115.87M | -203.92M | -282.32M | -2.22M | -159.87M |
Investing activities | |||||
Purchases Of Investments | -175.56M | -369.64M | -876.25M | -174.31M | -505.54M |
Investments In Property Plant And Equipment | -584K | -4.46M | -723K | -693K | -23K |
Acquisitions Net | 0 | -16.2M | 434.72M | 3.90M | -1.18M |
Cash generated by investing activities | 140.01M | 95.13M | -435.44M | -828M | -181.90M |
Financing activities | |||||
Common Stock Issued | 1.15M | 1.4M | 289.91M | 813.62M | 601K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -6.22M | -6.36M | -147K | -957K | 0 |
Repayments of term debt | 0 | 0 | -30.92M | -300K | 333.74M |
Cash used in financing activities | -33.86M | -4.96M | 925.39M | 858.23M | 333.97M |
Net Change In Cash | -9.71M | -113.75M | 207.62M | -39.59M | -7.80M |
Cash at end of period | 176.49M | 186.21M | 299.96M | 28.00M | 67.59M |
| Data source | Data source | Data source | Data source |